PT  - JOURNAL ARTICLE
AU  - Liu, Michelle
AU  - Loxton, Matthew
TI  - Patient Journey: A Qualitative Study of Hepatocellular Carcinoma Patient Experience
AID  - 10.1101/2025.03.04.25320693
DP  - 2025 Jan 01
TA  - medRxiv
PG  - 2025.03.04.25320693
4099  - http://medrxiv.org/content/early/2025/03/10/2025.03.04.25320693.short
4100  - http://medrxiv.org/content/early/2025/03/10/2025.03.04.25320693.full
AB  - Patients living with hepatocellular carcinoma (HCC) face significant barriers to receiving quality care, including delays in diagnosis and treatment, disease stigma, and financial challenges. This paper develops a three-part measurement system to categorize patient experiences of the care journey. Patient experiences were classified in terms of grounded constructs such as education, self-advocacy, and medical record utilization, as well as integrated care teams, including support groups, counselors, dietitians, palliative care providers, and navigators. These constructs were additionally cross-categorized in terms of care quality and root cause.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Blue Faery Liver Cancer AssociationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Blue Faery Liver Cancer Assoc IRB granted approvalI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors